Which has the lower trailing P/E, BMRN or BTSG?

BTSG has the lower trailing P/E: BMRN trades at 147.54 and BTSG at 46.27. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMRN or BTSG?

Over the past five years, BTSG grew revenue faster — BMRN at a 12.19% CAGR versus BTSG at 18.92%.

BioMarin Pharmaceutical Inc. (BMRN) vs BrightSpring Health Services, Inc. Common Stock (BTSG)

A side-by-side comparison of BioMarin Pharmaceutical Inc. and BrightSpring Health Services, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BMRN

BioMarin Pharmaceutical Inc.

$11.12B

$57.54HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

BTSG

BrightSpring Health Services, Inc. Common Stock

$12.17B

$62.00HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BMRN vs BTSG

growth of $100 · dividends reinvested · last 3y

BMRN -37.6% (-14.6%/yr)BTSG +463.6% (+78.0%/yr)BTSG compounded faster over this window

Log scale — wide-divergence pair

BMRN BTSG

BMRN vs BTSG: by the numbers

•BTSG is the larger company ($12.17B vs $11.12B market cap).
•BTSG trades at the lower trailing earnings multiple (46.27 vs 147.54 P/E), one valuation lens rather than an overall verdict.
•BTSG grew revenue faster over the past five years (18.92% vs 12.19% CAGR).

Metrics side by side

Valuation

Metric	BMRN	BTSG
P/E ratio	147.54	46.27
Forward P/E	N/A	34.10
PEG ratio	N/A	0.95
P/S ratio	3.26	0.85
P/B ratio	1.76	5.94
EV / EBITDA	33.90	21.92
FCF yield	6.59%	3.31%

Profitability

Metric	BMRN	BTSG
Gross margin	75.55%	12.38%
Operating margin	16.56%	3.33%
Net margin	2.14%	2.05%
ROE	1.15%	14.35%
ROIC	1.40%	8.97%

Growth (annualized)

Metric	BMRN	BTSG
Revenue CAGR (5Y)	12.19%	18.92%
EPS CAGR (5Y)	-17.46%	50.94%
FCF CAGR (5Y)	33.84%	9.24%
Total return CAGR (5Y)	-5.59%	N/A

Frequently asked

Which has the lower trailing P/E, BMRN or BTSG?: BTSG has the lower trailing P/E: BMRN trades at 147.54 and BTSG at 46.27. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMRN or BTSG?: Over the past five years, BTSG grew revenue faster — BMRN at a 12.19% CAGR versus BTSG at 18.92%.

Go deeper

Full BMRN analysis Full BTSG analysis Interactive comparison tool

Dig into the metrics

BioMarin Pharmaceutical P/E ratio BrightSpring Health Services, Inc. Common Stock P/E ratio BioMarin Pharmaceutical ROE BrightSpring Health Services, Inc. Common Stock ROE BioMarin Pharmaceutical operating margin BrightSpring Health Services, Inc. Common Stock operating margin BioMarin Pharmaceutical revenue growth BrightSpring Health Services, Inc. Common Stock revenue growth BioMarin Pharmaceutical free cash flow BrightSpring Health Services, Inc. Common Stock free cash flow

BioMarin Pharmaceutical & BrightSpring Health Services, Inc. Common Stock appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.